VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE
AML2521
Phase 2 small_molecule active
Quick answer
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE for Acute Myeloid Leukemia with NPM1 mutation is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Acute Myeloid Leukemia with NPM1 mutation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active